A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bánhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM.
van Leeuwen R, et al. Among authors: van leth f, van weert l, van eeden a, van der valk m.
AIDS. 2003 May 2;17(7):987-99. doi: 10.1097/00002030-200305020-00007.
AIDS. 2003.
PMID: 12700448
Clinical Trial.